Cormedix Inc Stock Forecast, Predictions & Price Target

Analyst price target for CRMD

Based on 3 analysts offering 12 month price targets for Cormedix Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell CRMD stock?

Based on 3 analysts offering ratings for Cormedix Inc.
Strong Buy
0 analysts 0%
3 analysts 100%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CRMD stock forecasts and price targets.

CRMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
RBC Capital
Top 18%
BuyInitiates Coverage On$6.00+63.49%2023-08-10
Bottom 2%
JMP Securities
Bottom 5%

1 of 1

CRMD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
STRO$3.30$17.50+430.30%Strong Buy
FENC$7.49$16.50+120.29%Strong Buy

Cormedix Stock Forecast FAQ

Is Cormedix Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CRMD) stock is to Buy CRMD stock.

Out of 3 analysts, 0 (0%) are recommending CRMD as a Strong Buy, 3 (100%) are recommending CRMD as a Buy, 0 (0%) are recommending CRMD as a Hold, 0 (0%) are recommending CRMD as a Sell, and 0 (0%) are recommending CRMD as a Strong Sell.

If you're new to stock investing, here's how to buy Cormedix stock.

What is CRMD's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CRMD price target, the average CRMD price target is $12.33, with the highest CRMD stock price forecast at $19.00 and the lowest CRMD stock price forecast at $6.00.

On average, Wall Street analysts predict that Cormedix's share price could reach $12.33 by Aug 10, 2024. The average Cormedix stock price prediction forecasts a potential upside of 236.05% from the current CRMD share price of $3.67.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.